Who makes 89Zr-DFO-N-Suc-C9scFv?

89Zr-DFO-N-Suc-C9scFv is developed by Var2 Pharmaceuticals.

What development phase is 89Zr-DFO-N-Suc-C9scFv in?

89Zr-DFO-N-Suc-C9scFv is in Phase 1.

Last reviewed 2026-05-15 · How we verify

89Zr-DFO-N-Suc-C9scFv

Var2 Pharmaceuticals · Phase 1 active Biologic

At a glance

Generic name	89Zr-DFO-N-Suc-C9scFv
Sponsor	Var2 Pharmaceuticals
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

89Zr-DFO-N-Suc-C9scFv CI brief — competitive landscape report
89Zr-DFO-N-Suc-C9scFv updates RSS · CI watch RSS
Var2 Pharmaceuticals portfolio CI